989342859	989342859	CD	B-NP	O
|	|	NN	I-NP	O
GDMH	GDMH	NN	I-NP	O
|	|	NN	I-NP	O
69162686	69162686	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1595799	1595799	CD	B-NP	O
|	|	CC	I-NP	O
8/18/2005	8/18/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/7/2005	11/7/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/7/2005	9/7/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
FERRIGNO	FERRIGNO	NNP	B-NP	O
,	,	,	O	O
CASEY	CASEY	NNP	B-NP	O
PABLO	PABLO	NNP	I-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Cardiology	Cardiology	NNP	B-NP	O
Team	Team	NNP	I-NP	O
VT	VT	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
CARE	CARE	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Geoffrey	Geoffrey	NNP	B-NP	O
D.	D.	NNP	I-NP	O
Heebsh	Heebsh	NNP	I-NP	O
MD	MD	NNP	I-NP	O
,	,	,	O	O
PHD	PHD	NNP	B-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
PROBLEMS/DIAGNOSES	PROBLEMS/DIAGNOSES	NN	B-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
;	;	:	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
;	;	:	O	O
hypertension	hypertension	NN	B-NP	O
;	;	:	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
;	;	:	O	O
and	and	CC	O	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Briefly	Briefly	NNP	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
82-year-old	82-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
10	10	CD	I-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
15	15	CD	I-NP	O
%	%	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
2	2	CD	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
with	with	IN	B-PP	O
being	be	VBG	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
from	from	IN	B-PP	O
one	one	CD	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
room	room	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
without	without	IN	B-PP	O
becoming	become	VBG	B-VP	O
short	short	RB	B-ADVP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
;	;	:	O	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
pounds	pound	NNS	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
;	;	:	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
,	,	,	I-NP	O
2-pillow	2-pillow	JJ	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
awakened	awaken	VBN	B-VP	O
from	from	IN	B-PP	O
sleep	sleep	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sudden	sudden	JJ	I-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
where	where	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
saturating	saturate	VBG	I-VP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
and	and	CC	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
,	,	,	O	O
sublingual	sublingual	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
topical	topical	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Cardiology	Cardiology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
who	who	WP	B-NP	O
diagnosed	diagnose	VBD	B-VP	O
him	him	PRP	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
CHF	CHF	NN	I-NP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
physical	physical	JJ	I-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
with	with	IN	B-PP	O
bibasilar	bibasilar	JJ	B-NP	O
opacities	opacity	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-NP	O
likely	likely	JJ	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
home	home	NN	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
100s	100s	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
110s	110s	CD	B-NP	I-DNA
.	.	.	O	O

His	His	PRP$	B-NP	O
course	course	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
hospital	hospital	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
nonsustained	nonsustained	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
through	through	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
EF	EF	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Laismode	Laismode	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
elective	elective	JJ	B-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
AICD	AICD	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
15	15	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
MI	MI	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
for	for	IN	B-PP	O
cholelithiasis	cholelithiasis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
probable	probable	JJ	B-NP	O
prostate	prostate	NN	I-NP	O
?	?	.	O	O
?	?	.	O	O
___	___	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
had	have	VBD	B-VP	O
included	include	VBN	I-VP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
KCl	KCl	NN	B-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Levoxyl	Levoxyl	NNP	B-NP	O
150	150	CD	I-NP	O
mcg	mcg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
atenelol	atenelol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
insomnia	insomnia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Ativan	Ativan	IN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
Transfer	Transfer	NN	I-NP	O
medications	medication	NNS	I-NP	O
include	include	VBP	B-VP	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
150	150	CD	I-NP	O
mcg	mcg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
atenelol	atenelol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
KCl	KCl	NN	B-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Ativan	Ativan	IN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
b.i.d.	b.i.d.	VBP	B-VP	O
SOCIAL	SOCIAL	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
ex-smoker	ex-smoker	NN	I-NP	O
and	and	CC	O	O
quit	quit	VB	B-VP	O
smoking	smoking	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
20	20	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HSITORY	HSITORY	NN	I-NP	O
:	:	:	O	O
Both	Both	CC	O	O
the	the	DT	B-NP	O
parents	parent	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
are	be	VBP	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
CAD	CAD	NN	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
70s	70	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMIANTION	EXAMIANTION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
upon	upon	IN	B-PP	O
arriving	arrive	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
;	;	:	O	O
temperature	temperature	NN	B-NP	O
was	be	VBD	B-VP	O
94.5	94.5	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
was	be	VBD	B-VP	O
64	64	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
120/60	120/60	CD	B-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
were	be	VBD	B-VP	O
20	20	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
saturating	saturate	VBG	I-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Examination	Examination	NN	B-NP	O
was	be	VBD	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
JVP	JVP	NN	B-NP	B-protein
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
jaw	jaw	NN	I-NP	O
and	and	CC	I-NP	O
moist	moist	NN	I-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
frequent	frequent	JJ	B-NP	O
ectopy	ectopy	NN	I-NP	O
and	and	CC	I-NP	O
S1	S1	NN	I-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
S3	S3	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
S4	S4	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
faint	faint	JJ	I-NP	O
left	left	JJ	I-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
pitting	pitting	NN	I-NP	O
edema	edema	NN	I-NP	O
but	but	CC	O	O
slightly	slightly	RB	B-VP	O
cool	cool	VBP	I-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
examination	examination	NN	I-NP	O
is	be	VBZ	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
.	.	.	O	O

CBC	CBC	NN	B-NP	B-protein
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
2035	2035	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
1.3	1.3	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
PTT	PTT	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
37.4	37.4	CD	B-NP	I-protein
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
performed	perform	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
15	15	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
left	left	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
and	and	CC	O	O
mild	mild	JJ	B-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ETT	ETT	NN	I-NP	O
myoview	myoview	NN	I-NP	O
performed	perform	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
fixed	fix	VBN	I-NP	O
defect	defect	NN	I-NP	O
inferiorly	inferiorly	RB	B-ADVP	O
and	and	CC	I-ADVP	O
inferolaterally	inferolaterally	RB	I-ADVP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lateral	lateral	JJ	I-NP	O
wall	wall	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
with	with	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
;	;	:	O	O
right	right	JJ	B-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
with	with	IN	B-PP	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
V1	V1	NN	B-NP	O
through	through	IN	B-PP	O
V4	V4	NN	B-NP	B-protein
;	;	:	O	O
Q	Q	NN	B-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aVF	aVF	NN	B-NP	O
;	;	:	O	O
first-degree	first-degree	JJ	B-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
fascicular	fascicular	JJ	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chest	ch	JJS	I-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
with	with	IN	B-PP	O
bibasilar	bibasilar	JJ	B-NP	O
opacities	opacity	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
atelectasis	atelectasis	NN	B-NP	O
versus	versus	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

Admission	Admission	NN	B-NP	O
EKG	EKG	NN	I-NP	O
here	here	RB	B-ADVP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

Admission	Admission	NN	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
costophrenic	costophrenic	JJ	I-NP	O
angle	angle	NN	I-NP	O
blunting	blunting	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Subjectively	Subjectively	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
82-year-old	82-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
15	15	CD	I-NP	O
%	%	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Las	Las	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Network	Network	NNP	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
elective	elective	JJ	I-NP	O
automatic	automatic	JJ	I-NP	O
implantable	implantable	JJ	I-NP	O
cardioverter-defibrillator	cardioverter-defibrillator	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
inferior	inferior	JJ	B-ADJP	O
in	in	IN	B-PP	O
area	area	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
ETT-MIBI	ETT-MIBI	NN	I-NP	B-protein
was	be	VBD	B-VP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
lateral	lateral	JJ	I-NP	O
wall	wall	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
fixed	fix	VBN	I-NP	O
inferior	inferior	JJ	I-NP	O
and	and	CC	I-NP	O
inferolateral	inferolateral	JJ	I-NP	O
defect	defect	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
statin	statin	NN	B-NP	O
and	and	CC	O	O
restarted	restart	VBD	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
dominant	dominant	JJ	I-NP	O
system	system	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
left	left	JJ	I-NP	O
main	main	JJ	I-NP	O
or	or	CC	I-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
left	left	JJ	I-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

Ejection	Ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
at	at	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	O	O
dilated	dilate	VBN	B-VP	O
left	leave	VBD	B-VP	O
atrium	atrium	NN	B-NP	O
and	and	CC	O	O
dilated	dilated	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
wedge	wedge	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
42	42	CD	B-NP	O
and	and	CC	I-NP	O
2	2	CD	I-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
BNP	BNP	NN	I-NP	O
of	of	IN	B-PP	O
2035	2035	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
,	,	,	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
digoxin	digoxin	NN	B-NP	O
.	.	.	O	O

Hydralazine	Hydralazine	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
demonstrated	demonstrate	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
left	left	JJ	B-NP	O
heart-filling	heart-filling	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
subsequently	subsequently	RB	B-ADVP	O
with	with	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
4	4	CD	I-NP	O
liters	liter	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADJP	O
euvolemic	euvolemic	JJ	I-ADJP	O
on	on	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
Lasix	Lasix	NNP	I-NP	O
to	to	TO	B-PP	O
being	be	VBG	B-VP	O
slightly	slightly	RB	B-ADJP	O
dry	dry	JJ	I-ADJP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
increased	increase	VBN	B-NP	O
CO2	CO2	NN	I-NP	B-protein
but	but	CC	O	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
BUN	BUN	NN	I-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
changed	change	VBN	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Lasix	Lasix	NNP	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s	90s	CD	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
100s	100s	CD	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
EP	EP	NN	B-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
admission	admission	NN	I-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
fascicular	fascicular	JJ	I-NP	O
block	block	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
first-degree	first-degree	JJ	I-NP	O
arteriovenous	arteriovenous	JJ	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
suddenly	suddenly	RB	B-ADJP	O
bradycardic	bradycardic	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
30s	30s	CD	I-NP	O
and	and	CC	I-NP	O
40s	40s	CD	I-NP	O
with	with	IN	B-PP	O
nonsustained	nonsustained	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
x30	x30	CD	B-NP	O
beats	beat	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
second-degree	second-degree	JJ	I-NP	O
arteriovenous	arteriovenous	JJ	I-NP	O
block	block	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

Zoll	Zoll	NN	B-NP	O
pads	pad	NNS	I-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
atropine	atropine	NN	B-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bedside	bedside	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
back	back	RB	B-ADVP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
with	with	IN	B-PP	O
automatic	automatic	JJ	B-NP	O
implantable	implantable	JJ	I-NP	O
cardioverter-defibrillator	cardioverter-defibrillator	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
with	with	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
resynchronization	resynchronization	NN	I-NP	O
therapy	therapy	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
interrogated	interrogate	VBN	I-VP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	O	O
?	?	.	O	O
?	?	.	O	O
___	___	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
were	be	VBD	B-VP	O
confined	confine	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Valko	Valko	NNP	I-NP	O
in	in	IN	B-PP	O
EP	EP	NNP	B-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
a.m.	a.m.	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
vigorous	vigorous	JJ	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
advised	advise	VBN	I-VP	O
to	to	TO	I-VP	O
restart	restart	VB	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	RB	B-ADVP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patients	patient	NNS	I-NP	O
'	'	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
and	and	CC	I-NP	O
thyroid	thyroid	NN	I-NP	O
function	function	NN	I-NP	O
test	test	NN	I-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
sick	sick	JJ	B-NP	O
euthyroid	euthyroid	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
levothyroxine	levothyroxine	NN	B-NP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
given	give	VBN	I-VP	O
trazodone	trazodone	NN	B-NP	O
and	and	CC	I-NP	O
Ativan	Ativan	NNP	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
somewhat	somewhat	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
automatic	automatic	JJ	B-NP	O
implantable	implantable	JJ	I-NP	O
cardioverter-defibrillator	cardioverter-defibrillator	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
oriented	orient	VBN	I-VP	O
to	to	TO	B-PP	O
time	time	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
later	later	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Genitourinary	Genitourinary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
bloody	bloody	JJ	B-NP	O
urine	urine	NN	I-NP	O
after	after	IN	B-PP	O
receiving	receive	VBG	B-VP	O
heparin	heparin	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
thought	think	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
Foley	Foley	NNP	B-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
clots	clot	NNS	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
significant	significant	JJ	B-NP	O
hematuria	hematuria	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O
?	?	.	O	O
___	___	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
Foley	Foley	NNP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
and	and	CC	O	O
bladder	bladder	NN	B-NP	O
irrigation	irrigation	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
was	be	VBD	B-VP	O
pink	pink	NN	B-NP	O
colored	color	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
leakage	leakage	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
replaced	replace	VBN	I-VP	O
given	give	VBN	I-VP	O
good	good	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
pink-colored	pink-colored	JJ	B-NP	O
urine	urine	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
clots	clot	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
pneumoboots	pneumoboot	NNS	B-NP	O
given	give	VBP	B-VP	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
automatic	automatic	JJ	I-NP	O
implantable	implantable	JJ	I-NP	O
cardioverter-defibrillator	cardioverter-defibrillator	NN	I-NP	O
placement	placement	NN	I-NP	O
and	and	CC	I-NP	O
hematuria	hematuria	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
clindamycin	clindamycin	NN	B-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
clindamycin	clindamycin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
through	through	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
Lasix	Lasix	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
150	150	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Ativan	Ativan	NNP	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
insomnia	insomnia	NN	I-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
insomnia	insomnia	NNP	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
oxide	oxide	NN	I-NP	O
800	800	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
KCl	KCl	NN	B-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
diet	diet	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	RB	B-ADVP	O
;	;	:	O	O
continue	continue	VB	B-VP	O
a	a	DT	B-NP	O
low-cholesterol	low-cholesterol	NN	I-NP	O
,	,	,	O	O
low-fat	low-fat	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
low-sodium	low-sodium	NN	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	B-NP	O
calories	calorie	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

ACTIVITIES	ACTIVITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
vigorous	vigorous	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
lifting	lifting	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
shoulder	shoulder	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
drive	drive	VB	I-VP	O
until	until	IN	B-SBAR	O
a	a	DT	B-NP	O
followup	followup	NN	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Isaias	Isaias	NNP	I-NP	O
Topper	Topper	NNP	I-NP	O
and	and	CC	O	O
Landon	Landon	NNP	B-NP	O
Ducayne	Ducayne	NNP	I-NP	O
,	,	,	O	O
nurse	nurse	NN	B-NP	O
practitioner	practitioner	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
clinic	clinic	NN	I-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
appointment	appointment	NN	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Marcelo	Marcelo	NNP	I-NP	O
Annis	Annis	NNP	I-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
a.m.	a.m.	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Hamarbo	Hamarbo	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-2996583	2-2996583	CD	B-NP	O
SS	SS	NN	I-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
August	August	NNP	B-NP	O
Shelby	Shelby	NNP	I-NP	O
Vaupel	Vaupel	NNP	I-NP	O
MD	MD	NNP	I-NP	O
,	,	,	O	O
PHD	PHD	NNP	B-NP	O
Tule	Tule	NNP	I-NP	O
Boulevard	Boulevard	NNP	I-NP	O
,	,	,	O	O
Cima	Cima	NNP	B-NP	O
,	,	,	O	O
Georgia	Georgia	NNP	B-NP	O
24898	24898	CD	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
FACK	FACK	NNP	B-NP	O
,	,	,	O	O
JAMAL	JAMAL	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
EULER	EULER	NNP	B-NP	O
,	,	,	O	O
BRUCE	BRUCE	NNP	B-NP	O
JACQUES	JACQUES	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2581337	2581337	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
8/9/05	8/9/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/1/05	9/1/05	CD	B-NP	O

